ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Aro Biotherapeutics signs licensing agreement worth up to $1.4bn
January 13, 2020Aro Biotherapeutics, a biotech firm engaged in the development of protein biologics called Centyrins, has signed a licencing deal that can potentially generate up to $1.4bn for the company. -
Janssen alums' Aro Biotherapeutics takes aim at centyrins with $13M round
December 27, 2018A pair of former Janssen R&D leaders founded Aro Biotherapeutics early this year to develop centyrins—small proteins that could potentially work like antibodies without the accompanying challenges..... -
Isogenica inks licensing deal with Aro Biotherapeutics for development of scaffold molecules
July 31, 2018Isogenica has inked a licensing deal with Aro Biotherapeutics to use its in vitro polypeptide display systems for the development of Aro’s scaffold molecule technology.
Pharma Sources Insight January 2025
